lunes, 19 de octubre de 2026

GLP-1 Drugs and Obstructive Sleep Apnea: How Weight Loss Medications Improve Breathing During Sleep

https://www.news-medical.net/health/GLP-1-Drugs-and-Obstructive-Sleep-Apnea-How-Weight-Loss-Medications-Improve-Breathing-During-Sleep.aspx What can treatments targeting weight and metabolism offer people with obstructive sleep apnea, and which questions must clinical trials still answer? Obstructive sleep apnea (OSA) is characterized by recurrent collapse of the upper airway during sleep, causing repeated airflow obstruction and leading to loud snoring, frequent awakenings, and excessive daytime sleepiness. Over time, fragmented sleep and recurrent nocturnal awakenings contribute to chronic fatigue, reduced energy levels, and impaired quality of life.

No hay comentarios:

Publicar un comentario